{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blinded+%28placebo%29&page=41", "query": { "intervention": "Blinded (placebo)", "page": 41 }, "page_size": 10 }, "pagination": { "page": 41, "page_size": 10, "total_count": 2208, "total_pages": 221, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blinded+%28placebo%29&page=42&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blinded+%28placebo%29&page=40&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-16T18:14:32.233Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02623829", "title": "Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post-operative Excessive Scarring" ], "interventions": [ { "name": "Botulinum Toxin", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2015-12-01", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2020-12-08", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02623829" }, { "nct_id": "NCT00769041", "title": "A Thorough EKG Safety Study of TA-1790 (Avanafil)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Erectile Dysfunction" ], "interventions": [ { "name": "moxifloxacin", "type": "DRUG" }, { "name": "avanafil", "type": "DRUG" }, { "name": "sugar pill", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VIVUS LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 57, "start_date": "2008-10", "completion_date": "2009-01", "has_results": false, "last_update_posted_date": "2011-01-07", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00769041" }, { "nct_id": "NCT01489046", "title": "Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV-1 Infection" ], "interventions": [ { "name": "BMS-986001", "type": "DRUG" }, { "name": "Placebo matching with BMS-986001", "type": "DRUG" }, { "name": "Efavirenz", "type": "DRUG" }, { "name": "Lamivudine", "type": "DRUG" }, { "name": "Tenofovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 297, "start_date": "2011-02", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2016-04-15", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 18, "location_summary": "Sacramento, California • Orlando, Florida • West Palm Beach, Florida + 15 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01489046" }, { "nct_id": "NCT02459886", "title": "Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson's Disease", "Healthy" ], "interventions": [ { "name": "BIIB054", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 66, "start_date": "2015-07-01", "completion_date": "2017-11-20", "has_results": false, "last_update_posted_date": "2019-08-08", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 9, "location_summary": "Washington D.C., District of Columbia • Hallandale, Florida • Oviedo, Florida + 6 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Hallandale", "state": "Florida" }, { "city": "Oviedo", "state": "Florida" }, { "city": "Evansville", "state": "Indiana" }, { "city": "Farmington Hills", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02459886" }, { "nct_id": "NCT05816395", "title": "Safety and Efficacy of RHH646 for Knee Osteoarthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "RHH646", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "35 Years to 75 Years" }, "enrollment_count": 82, "start_date": "2023-05-31", "completion_date": "2025-02-24", "has_results": true, "last_update_posted_date": "2026-03-31", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 4, "location_summary": "Lincoln, California • Winter Park, Florida • Houston, Texas + 1 more", "locations": [ { "city": "Lincoln", "state": "California" }, { "city": "Winter Park", "state": "Florida" }, { "city": "Houston", "state": "Texas" }, { "city": "Sugar Land", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05816395" }, { "nct_id": "NCT02607930", "title": "Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV-1 Infection" ], "interventions": [ { "name": "ABC/DTG/3TC", "type": "DRUG" }, { "name": "B/F/TAF", "type": "DRUG" }, { "name": "ABC/DTG/3TC Placebo", "type": "DRUG" }, { "name": "B/F/TAF Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 631, "start_date": "2015-11-13", "completion_date": "2021-07-02", "has_results": true, "last_update_posted_date": "2022-03-02", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 78, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 57 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02607930" }, { "nct_id": "NCT00262067", "title": "A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Breast Cancer" ], "interventions": [ { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Chemotherapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1237, "start_date": "2005-12", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2013-12-13", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 5, "location_summary": "Fullerton, California • Santa Barbara, California • Iowa City, Iowa + 2 more", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "Santa Barbara", "state": "California" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Sioux City", "state": "Iowa" }, { "city": "Wichita", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00262067" }, { "nct_id": "NCT03540628", "title": "Thiamine, Vitamin C and Hydrocortisone in the Treatment of Septic Shock", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Septic Shock" ], "interventions": [ { "name": "Thiamine and Vitamin C", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Corewell Health South", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 17, "start_date": "2018-02-26", "completion_date": "2020-06-30", "has_results": false, "last_update_posted_date": "2024-12-09", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 1, "location_summary": "Saint Joseph, Michigan", "locations": [ { "city": "Saint Joseph", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03540628" }, { "nct_id": "NCT06572228", "title": "Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "dupilumab", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" }, { "name": "ICS/LABA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "12 Years to 80 Years" }, "enrollment_count": 120, "start_date": "2024-08-26", "completion_date": "2027-04-24", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 51, "location_summary": "Bakersfield, California • La Jolla, California • Lancaster, California + 47 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06572228" }, { "nct_id": "NCT05633407", "title": "Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postural Orthostatic Tachycardia Syndrome" ], "interventions": [ { "name": "Efgartigimod", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "argenx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 53, "start_date": "2022-09-23", "completion_date": "2024-04-18", "has_results": true, "last_update_posted_date": "2025-05-23", "last_synced_at": "2026-10-16T18:14:32.233Z", "location_count": 11, "location_summary": "La Jolla, California • Palo Alto, California • Glenview, Illinois + 8 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Glenview", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05633407" } ] }